Bank Julius Baer & Co’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-170
| Closed | -$16.4K | – | 562 |
|
|
2023
Q4 | $16.4K | Sell |
170
-822
| -83% | -$79.3K | ﹤0.01% | 513 |
|
|
2023
Q3 | $120K | Sell |
992
-52
| -5% | -$6.29K | ﹤0.01% | 409 |
|
|
2023
Q2 | $120K | Sell |
1,044
-2,855
| -73% | -$328K | ﹤0.01% | 443 |
|
|
2023
Q1 | $537K | Sell |
3,899
-1,361
| -26% | -$187K | ﹤0.01% | 337 |
|
|
2022
Q4 | $682K | Sell |
5,260
-1,696
| -24% | -$220K | ﹤0.01% | 310 |
|
|
2022
Q3 | $769K | Buy |
6,956
+3,638
| +110% | +$402K | 0.01% | 289 |
|
|
2022
Q2 | $249K | Sell |
3,318
-3,502
| -51% | -$263K | ﹤0.01% | 391 |
|
|
2022
Q1 | $533K | Sell |
6,820
-4,217
| -38% | -$330K | ﹤0.01% | 342 |
|
|
2021
Q4 | $994K | Buy |
11,037
+7,601
| +221% | +$685K | 0.01% | 355 |
|
|
2021
Q3 | $318K | Sell |
3,436
-63
| -2% | -$5.83K | ﹤0.01% | 495 |
|
|
2021
Q2 | $272K | Buy |
+3,499
| New | +$272K | ﹤0.01% | 536 |
|
|
2021
Q1 | – | Sell |
-3,173
| Closed | -$541K | – | 890 |
|
|
2020
Q4 | $541K | Buy |
3,173
+553
| +21% | +$94.3K | ﹤0.01% | 439 |
|
|
2020
Q3 | $318K | Buy |
2,620
+720
| +38% | +$87.4K | ﹤0.01% | 449 |
|
|
2020
Q2 | $272K | Buy |
+1,900
| New | +$272K | ﹤0.01% | 426 |
|